Does RAMUCIRUMAB Cause Malignant pleural effusion? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant pleural effusion have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 0.1% of all adverse event reports for RAMUCIRUMAB.
7
Reports of Malignant pleural effusion with RAMUCIRUMAB
0.1%
of all RAMUCIRUMAB reports
5
Deaths
3
Hospitalizations
How Dangerous Is Malignant pleural effusion From RAMUCIRUMAB?
Of the 7 reports, 5 (71.4%) resulted in death, 3 (42.9%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Malignant pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMUCIRUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
What Other Drugs Cause Malignant pleural effusion?
PEMBROLIZUMAB (97)
CARBOPLATIN (65)
BEVACIZUMAB (64)
LETROZOLE (63)
NIVOLUMAB (61)
FULVESTRANT (58)
PACLITAXEL (58)
PALBOCICLIB (55)
CYCLOPHOSPHAMIDE (49)
OSIMERTINIB (46)
Which RAMUCIRUMAB Alternatives Have Lower Malignant pleural effusion Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE